Skip to main content
. Author manuscript; available in PMC: 2012 Jun 26.
Published in final edited form as: Cephalalgia. 2011 Jan 7;31(5):614–624. doi: 10.1177/0333102410391487

Figure 5.

Figure 5

Pro-CT (calcitonin precursor) immunoreactivity in glia. Cultures were treated with (A) dimethylsulfoxide (DMSO) (Veh) or (B) combination of 10 μg/ml Aza-dC and 10 nM TSA (Aza+TSA) as in Figure 4C. Cultures were stained with anti–glial fibrillary acidic protein (GFAP) antibodies (glial marker, green), ToPro3 (nucleus marker, blue) and anti-pro-CT antibodies (red). Merged images and magnification bars are shown.